For self-funded employers, pharmacy benefit decisions that used to be relatively contained are now directly affecting stop-loss exposure and renewal pricing.
This projection marks the fourth consecutive year of elevated health care cost trends approaching double digits and extends one of the most sustained periods of health care inflation employers have faced in decades.